IP Library Granted Patent US 11,291,485
Granted Patent B2
US 11,291,485 · App. 16/552,912 · Granted Apr 5, 2022

Fenestrated implant

Inventors: Richard G. Mauldin (Erie, CO); Scott A. Yerby (Montara, CA); Mark A. Reiley (Delray Beach, FL); Bret W. Schneider (San Jose, CA)
Assignee: SI-Bone Inc.
A61B17/84A61B17/68A61B17/7055A61B17/1604A61B17/1664A61B17/1671A61B17/1697A61B17/1757A61B17/8897A61F2002/30995
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,291,485
App. No.
16/552,912
Granted
Apr 5, 2022
Kind
B2
Abstract

The present invention relates generally to implants used in medical procedures such as bone fixation or fusion. More specifically, this application relates to fenestrated implants used in bone fixation or fusion.

Claims (19)

1. An implant for bone fixation, the implant comprising:

an elongate body having a longitudinal axis, a distal end, a proximal end and a rectilinear cross sectional profile transverse to the longitudinal axis extending from a proximal half of the elongate body into a distal half of the elongate body, the rectilinear cross sectional profile comprising a plurality of faces and configured to minimize or reduce rotation and micromotion, each of the plurality of faces having a plurality of fenestrations, the plurality of fenestrations on each face being arranged in a staggered pattern, the elongate body having a central lumen located along the longitudinal axis and configured to receive a guide pin, wherein each of the plurality of fenestrations reach and provide access to the central lumen, wherein a concentration or number of fenestrations is higher in a distal half of the elongate body than in a proximal half, wherein the distal end of the elongate body is tapered to facilitate implantation into the bone, and wherein the elongate body has a bending strength or a shear strength of at least 0.5 relative to a reference elongate body with identical dimensions and material composition but without any fenestrations.

2. The implant of claim 1 , wherein the plurality of faces of the rectilinear cross section consists of exactly three faces.

3. The implant of claim 1 , wherein the plurality of faces of the rectilinear cross section consists of exactly four faces.

4. The implant of claim 1 , wherein the distal end of the elongate body is formed into one or more cutting edges.

5. The implant of claim 1 , wherein the fenestrations are located on a distal portion of the elongate body that is configured to be implanted within the sacrum of a patient while the proximal portion of the elongate body that is configured to be implanted within the ilium is free from fenestrations.

6. The implant of claim 1 , further comprising a cap on the proximal end of the elongate body, the cap having a hole sized to receive a guide pin.

7. The implant of claim 1 , wherein the elongate body has an inner surface and an outer surface that are porous.

8. The implant of claim 1 , wherein the elongate body has an inner surface and an outer surface that are roughened.

9. The implant of claim 1 , wherein the elongate body has an inner surface and an outer surface that are treated with a plasma coating.

10. The implant of claim 1 , wherein the elongate body has an inner surface and an outer surface that are coated with a biologic aid.

11. The implant of claim 10 , wherein the biologic aid is a bone morphogenetic protein.

12. The implant of claim 1 , wherein the elongate body has a length in the direction of the longitudinal axis that is about 35 mm to about 70 mm.

13. The implant of claim 1 , wherein the rectilinear cross section is triangular in shape with a height of about 10.5 mm and a base of about 12 mm.

14. The implant of claim 1 , wherein the rectilinear cross section has an inscribed diameter of about 7 mm.

15. The implant of claim 1 , wherein the rectilinear cross section has an inscribed diameter of about 4 mm to about 12 mm.

16. The implant of claim 1 , wherein the plurality of fenestrations on each face comprises a plurality of rows of fenestrations, and wherein on each face the fenestrations in a first row are staggered from the fenestrations in a second row.

17. The implant of claim 1 , wherein the fenestrations have a width between 0.2 to 0.6 of the width of the face.

18. The implant of claim 1 , wherein the fenestrations have a configuration that is non-circular.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2021
From: MAULDIN, RICHARD G.; YERBY, SCOTT A.; REILEY, MARK A.; SCHNEIDER, BRET W.
To: SI-BONE INC.
Reel/Frame 057735/0088 →
RELEASE OF SECURITY INTEREST Recorded Aug 12, 2021
From: SLR INVESTMENT CORP. (F/K/A SOLAR CAPITAL LTD., AS COLLATERAL AGENT)
To: SI-BONE, INC.
Reel/Frame 057182/0104 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded May 29, 2020
From: SI-BONE, INC.
To: SOLAR CAPITAL LTD., AS COLLATERAL AGENT
Reel/Frame 052795/0289 →
Continuity (3)
Continuation 13888249 · May 6, 2013
Provisional Application 61642681 · May 4, 2012
Related Publication 20200008850A1 · Jan 9, 2020
Cited By (12)
US 12,201,330 US 12,213,886 US 12,419,668 US 12,427,028 US 12,427,034 US 12,433,733 US 12,453,563 US 12,458,413 US 12,558,225 US 12,616,587 US 12,661,239 US 12,708,415